Cargando…
Reply: Optimum duration of breast cancer follow-up: a continuing controversy
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360442/ http://dx.doi.org/10.1038/sj.bjc.6603974 |
| _version_ | 1782153050469695488 |
|---|---|
| author | Montgomery, D A Dixon, J M |
| author_facet | Montgomery, D A Dixon, J M |
| author_sort | Montgomery, D A |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-2360442 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2007 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-23604422009-09-10 Reply: Optimum duration of breast cancer follow-up: a continuing controversy Montgomery, D A Dixon, J M Br J Cancer Letter to the Editor Nature Publishing Group 2007-10-22 2007-09-11 /pmc/articles/PMC2360442/ http://dx.doi.org/10.1038/sj.bjc.6603974 Text en Copyright © 2007 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Letter to the Editor Montgomery, D A Dixon, J M Reply: Optimum duration of breast cancer follow-up: a continuing controversy |
| title | Reply: Optimum duration of breast cancer follow-up: a continuing controversy |
| title_full | Reply: Optimum duration of breast cancer follow-up: a continuing controversy |
| title_fullStr | Reply: Optimum duration of breast cancer follow-up: a continuing controversy |
| title_full_unstemmed | Reply: Optimum duration of breast cancer follow-up: a continuing controversy |
| title_short | Reply: Optimum duration of breast cancer follow-up: a continuing controversy |
| title_sort | reply: optimum duration of breast cancer follow-up: a continuing controversy |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360442/ http://dx.doi.org/10.1038/sj.bjc.6603974 |
| work_keys_str_mv | AT montgomeryda replyoptimumdurationofbreastcancerfollowupacontinuingcontroversy AT dixonjm replyoptimumdurationofbreastcancerfollowupacontinuingcontroversy |